RAISING is a High-performance Method for Identifying Random Transgene Integration Sites

Both natural viral infections and therapeutic interventions using viral vectors pose significant risks of malignant transformation. Monitoring for clonal expansion of infected cells is important for detecting cancer. Here we developed a novel method of tracking clonality via the detection of transgene integration sites. RAISING (Rapid Amplification of Integration Sites without Interference by Genomic DNA contamination) is a sensitive, inexpensive alternative to established methods. Its compatibility with Sanger sequencing combined with our CLOVA (Clonality Value) software is critical for those without access to expensive high throughput sequencing. We analyzed samples from 688 individuals infected with the retrovirus HTLV-1, which causes adult T-cell leukemia/lymphoma (ATL) to model our method. We defined a clonality value identifying ATL patients with 100% sensitivity and 94.8% specificity, and our longitudinal analysis also demonstrates the usefulness of ATL risk assessment. Future studies will confirm the broad applicability of our technology, especially in the emerging gene therapy sector.

Citing Articles

A rapid and simple clonality assay for bovine leukemia virus-infected cells by amplified fragment length polymorphism (AFLP) analysis.

Kobayashi T, Makimoto S, Ohnuki N, Hossain M, Jahan M, Matsuo M Microbiol Spectr. 2024; 13(1):e0171424.

PMID: 39570050 PMC: 11705797. DOI: 10.1128/spectrum.01714-24.

HTLV-1 vaccination Landscape: Current developments and challenges.

Letafati A, Bahari M, Salahi Ardekani O, Nayerain Jazi N, Nikzad A, Norouzi F Vaccine X. 2024; 19:100525.

PMID: 39105133 PMC: 11298643. DOI: 10.1016/j.jvacx.2024.100525.

Chimeric provirus of bovine leukemia virus/SMAD family member 3 in cattle with enzootic bovine leukosis.

Nao N, Okagawa T, Nojiri N, Konnai S, Shimakura H, Tominaga M Arch Virol. 2024; 169(3):47.

PMID: 38366081 DOI: 10.1007/s00705-024-05970-3.

Establishment of a novel human T-cell leukemia virus type 1 infection model using cell-free virus.

Nagata K, Tezuka K, Kuramitsu M, Fuchi N, Hasegawa Y, Hamaguchi I J Virol. 2024; 98(2):e0186223.

PMID: 38294250 PMC: 10878273. DOI: 10.1128/jvi.01862-23.

HAS-Flow May Be an Adequate Method for Evaluating Human T-Cell Leukemia Virus Type 1 Infected Cells in Human T-Cell Leukemia Virus Type 1-Positive Rheumatoid Arthritis Patients Receiving Antirheumatic Therapies: A Retrospective Cross-Sectional....

Umekita K, Hashikura Y, Takaki A, Kimura M, Kawano K, Iwao C Viruses. 2023; 15(2).

PMID: 36851682 PMC: 9967177. DOI: 10.3390/v15020468.

References

Shimoyama M . Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol. 1991; 79(3):428-37. DOI: 10.1111/j.1365-2141.1991.tb08051.x. View

Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A . HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986; 1(8488):1031-2. DOI: 10.1016/s0140-6736(86)91298-5. View

Tsai S, Zheng Z, Nguyen N, Liebers M, Topkar V, Thapar V . GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat Biotechnol. 2014; 33(2):187-197. PMC: 4320685. DOI: 10.1038/nbt.3117. View

Hill J, Demarest B, Bisgrove B, Su Y, Smith M, Yost H . Poly peak parser: Method and software for identification of unknown indels using sanger sequencing of polymerase chain reaction products. Dev Dyn. 2014; 243(12):1632-6. PMC: 4525701. DOI: 10.1002/dvdy.24183. View

Lusso P, Cocchi F, Balotta C, Markham P, Louie A, Farci P . Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1. J Virol. 1995; 69(6):3712-20. PMC: 189087. DOI: 10.1128/JVI.69.6.3712-3720.1995. View

Schmidt M, Schwarzwaelder K, Bartholomae C, Zaoui K, Ball C, Pilz I . High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR). Nat Methods. 2007; 4(12):1051-7. DOI: 10.1038/nmeth1103. View

Gabriel R, Eckenberg R, Paruzynski A, Bartholomae C, Nowrouzi A, Arens A . Comprehensive genomic access to vector integration in clinical gene therapy. Nat Med. 2009; 15(12):1431-6. DOI: 10.1038/nm.2057. View

Watanabe T . Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells. Blood. 2017; 129(9):1071-1081. PMC: 5374731. DOI: 10.1182/blood-2016-09-692574. View

Firouzi S, Lopez Y, Suzuki Y, Nakai K, Sugano S, Yamochi T . Development and validation of a new high-throughput method to investigate the clonality of HTLV-1-infected cells based on provirus integration sites. Genome Med. 2014; 6(6):46. PMC: 4097847. DOI: 10.1186/gm568. View

10.

Kataoka K, Nagata Y, Kitanaka A, Shiraishi Y, Shimamura T, Yasunaga J . Integrated molecular analysis of adult T cell leukemia/lymphoma. Nat Genet. 2015; 47(11):1304-15. DOI: 10.1038/ng.3415. View

11.

Saito M, Hasegawa H, Yamauchi S, Nakagawa S, Sasaki D, Nao N . A high-throughput detection method for the clonality of Human T-cell leukemia virus type-1-infected cells in vivo. Int J Hematol. 2020; 112(3):300-306. DOI: 10.1007/s12185-020-02935-5. View

12.

Nagasaka M, Yamagishi M, Yagishita N, Araya N, Kobayashi S, Makiyama J . Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1-associated myelopathy/tropical spastic paraparesis. Proc Natl Acad Sci U S A. 2020; 117(21):11685-11691. PMC: 7260950. DOI: 10.1073/pnas.1920346117. View

13.

Akari H, Nam K, Mori K, Otani I, Shibata H, Adachi A . Effects of SIVmac infection on peripheral blood CD4+CD8+ T lymphocytes in cynomolgus macaques. Clin Immunol. 1999; 91(3):321-9. DOI: 10.1006/clim.1999.4700. View

14.

Rosewick N, Durkin K, Artesi M, Marcais A, Hahaut V, Griebel P . Cis-perturbation of cancer drivers by the HTLV-1/BLV proviruses is an early determinant of leukemogenesis. Nat Commun. 2017; 8:15264. PMC: 5457497. DOI: 10.1038/ncomms15264. View

15.

Helmy M, Awad M, Mosa K . Limited resources of genome sequencing in developing countries: Challenges and solutions. Appl Transl Genom. 2016; 9:15-9. PMC: 4911431. DOI: 10.1016/j.atg.2016.03.003. View

16.

Hacein-Bey-Abina S, Le Deist F, Carlier F, Bouneaud C, Hue C, de Villartay J . Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med. 2002; 346(16):1185-93. DOI: 10.1056/NEJMoa012616. View

17.

Gessain A, Cassar O . Epidemiological Aspects and World Distribution of HTLV-1 Infection. Front Microbiol. 2012; 3:388. PMC: 3498738. DOI: 10.3389/fmicb.2012.00388. View

18.

Katsuya H, Islam S, Tan B, Ito J, Miyazato P, Matsuo M . The Nature of the HTLV-1 Provirus in Naturally Infected Individuals Analyzed by the Viral DNA-Capture-Seq Approach. Cell Rep. 2019; 29(3):724-735.e4. DOI: 10.1016/j.celrep.2019.09.016. View

19.

Kuramitsu M, Okuma K, Yamochi T, Sato T, Sasaki D, Hasegawa H . Standardization of Quantitative PCR for Human T-Cell Leukemia Virus Type 1 in Japan: a Collaborative Study. J Clin Microbiol. 2015; 53(11):3485-91. PMC: 4609719. DOI: 10.1128/JCM.01628-15. View

20.

Marcais A, Lhermitte L, Artesi M, Laurent C, Durkin K, Hahaut V . Targeted deep sequencing reveals clonal and subclonal mutational signatures in Adult T-cell leukemia/lymphoma and defines an unfavorable indolent subtype. Leukemia. 2020; 35(3):764-776. DOI: 10.1038/s41375-020-0900-3. View